October 10, 2019
MYELOMA CANADA PROUDLY APPOINTS 5 NEW DIRECTORS TO ITS BOARD
On October 3, Myeloma Canada announced that five leaders within the Canadian community have joined its Board of Directors.
“The appointment of our new Board members represents an exciting opportunity to broaden the voices and perspectives of Myeloma Canada” stated Johanne Mullen, Chair, Myeloma Canada. “These five individuals bring diverse experience to the table, covering the spectrum of law, business, health technology, relationship-building, patient advocacy as well as governance. Each was carefully selected because of their experience and passion for our cause: to empower the Canadian myeloma community through awareness, education and advocacy programs, while supporting clinical research so that a cure may be found.” Johanne added, “We welcome Antoinette Bozac, Emily Crowe, Lorelei Dalrymple, Mélanie Martel and Keith Taylor and look forward to their contributions to Myeloma Canada’s Board of Directors”.
Click here to read the press release.